Reaping the benefits of a Euro-Australian collaboration for biotechs: save on costs and time

Reaping the benefits of a Euro-Australian collaboration for biotechs: save on costs and time


Cromos Pharma CEO Dr Vlad Bogin is joined by Avance Clinical‘s CEO Yvonne Lungershausen to discuss some of the benefits available to biotechs by availing of a joint initiative that combines Australian tax benefits for clinical research with exceptional patient recruitment and retention in Eastern European markets. Read more here>>

This presentation was prepared January 2021 for activities around JP Morgan Healthcare Week. Please feel free to share this presentation with colleagues. If you have any queries please contact: inquiry@cromospharma.com.


Cromos Pharma proudly supports the Right2hope nonprofit platform, empowering patients to explore treatment options beyond traditional clinical trials. Through an intuitive, AI-supported matching algorithm, Right2hope connects patients with the most relevant expanded access, compassionate use, and right-to-try programs.

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us

OUR PUBLICATIONS